Los puntos clave no están disponibles para este artículo en este momento.
Recently, Fenton (2009) Fenton, A. 2009. Buddhism and Neuroethics: The Ethics of Pharmaceutical Cognitive Enhancement. Developing World Bioethics, 9: 47–56. Crossref, PubMed, Web of Science ® , Google Scholar has argued that Buddhist ethics can accommodate the use of attention-enhancing drugs, and Walker (2006 Walker, M. (2006). In praise of bio-happiness. IEET White Paper. Available at(Last accessed December 8, 2012) http://ieet.org/archive/IEET-02-BioHappiness.pdf (http://ieet.org/archive/IEET-02-BioHappiness.pdf) Google Scholar, 2009) has argued that future neurotechnologies may be used to enhance happiness and virtue. This paper uses a Western Buddhist perspective, drawing on many Buddhist traditions, to explore how emerging neurotechnologies may be used to suppress vices and enhance happiness and virtue. A Buddhist approach to the authenticity of technologically-mediated spiritual progress is discussed. The potential utility and dangers of mood manipulation for a Buddhist understanding of liberation are outlined. Then the ten paramitas of Theravadan Buddhism are explored to frame an exploration of the potential genes, neurochemicals and brain structures that could be targeted as part of a program of neurotechnological moral enhancement.
James J. Hughes (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: